Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Ayodeji Adegunsoye(University of Chicago), Rekha Vij(University of Chicago), Steven M. Montner(University of Chicago), Jonathan H. Chung(National Jewish Health), Donald Hedeker(Chicago Department of Public Health), Scully Hsu(University of Chicago), Lacey B. Robinson(Sanofi (United States)), Nina Patel(Columbia University Irving Medical Center), Evans R. Fernández Pérez(National Jewish Health), Mitchell Tener(University of Kansas Medical Center), Mary E. Strek(University of Chicago), Lena W. Chen(University of Chicago), Sam Bullick(University of California, Davis), Deepa Bhanot(University of Kansas Medical Center), Aliya N. Husain(University of Chicago), Imre Noth(University of Chicago), Matthew M. Churpek(University of Chicago), Justin M. Oldham(University of Michigan)
Cited by 125
Related Papers
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
|JAMA|2013|456
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Sarcoidosis-related Mortality in the United States from 1988 to 2007
|American Journal of Respiratory and Critical Care Medicine|2011|400